Further trial disruptions due to the Russian invasion of Ukraine
A further three trials have been disrupted by the Russia-Ukraine conflict since 28 April, bringing the total number to 11.
By
Ukraine
Latest in
Ukraine
Trial disruptions due to the Russian invasion of Ukraine
Eight trials have so far been disrupted due to the Russian invasion of Ukraine, and another eight may be impacted…
By
Clinical trials in Russia: big pharma makes moves but what’s the pipeline impact?
Certain big pharma companies have reconsidered their clinical trial footprint in Russia in response to the Ukraine invasion. Clinical Trials…
By
Pfizer to halt new clinical trial initiations in Russia amid Ukraine crisis
In an analysis by Clinical Trials Arena, Pfizer ranks ninth in the top 10 pharma companies with an ongoing and…
Tricida updates timeline for CKD drug trial data amid Ukraine crisis
Top-line data from the VALOR-CKD trial of veverimer is now expected in the fourth quarter of this year.
Top medical university in Russia pauses clinical trials, sample transport paralysed
Even if enrollment hiatus is lifted, logistical issues such as sending samples to and from Russia another setback.
By
Ukraine: Former FDA-er calls for agency to freeze Russian regulatory requests
There are at least five pharma companies and two research centres headquartered in Russia with a clinical trial site recruiting…
By
Karuna withdraws guidance on schizophrenia trial amid Russia-Ukraine crisis
The Phase III EMERGENT-3 trial is assessing the safety and efficacy of KarXT for schizophrenia in the US and Ukraine.